Saturday, October 31, 2026

CACI International, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

January 2, 2021

CACI International, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. CACI International, Inc.

7.7% sales growth and 13.36% return on equity

CACI International Inc, together with its subsidiaries, provides information solutions and services in North America and internationally.

CACI International, Inc.'s sales growth this year is expected to be 7.7% and 5.3% for next year.

Year-on-year quarterly revenue growth grew by 7%, now sitting on 5.82B for the twelve trailing months.

CACI International, Inc.'s sales growth for the next quarter is 7.7%. The company's growth estimates for the ongoing quarter and the next is 15.1% and 19.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.36%.

Volatility

CACI International, Inc.'s last day, last week, and last month's average volatility was 1.23%, 0.14%, and 0.16%, respectively.

CACI International, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.37%, 1.75%, and 1.99%, respectively.

CACI International, Inc.'s Stock Yearly Top and Bottom Value

CACI International, Inc.'s stock is valued at $249.52 at 04:22 EST, way below its 52-week high of $288.59 and way higher than its 52-week low of $156.15.

CACI International, Inc.'s Moving Average

CACI International, Inc.'s value is higher than its 50-day moving average of $241.68 and way higher than its 200-day moving average of $223.49.

2. Shopify

66.1% sales growth and 4.37% return on equity

Shopify Inc., a commerce company, provides a cloud-based multi-channel commerce platform for small and medium-sized businesses in Canada, the United States, the United Kingdom, Australia, and internationally.

Shopify's sales growth this year is expected to be 80.7% and 32.5% for next year.

Year-on-year quarterly revenue growth grew by 96.5%, now sitting on 2.46B for the twelve trailing months.

Shopify's sales growth for the next quarter is 66.1%. The company's growth estimates for the present quarter and the next is 195.3% and 200%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.37%.

Volatility

Shopify's last day, last week, and last month's average volatility was a negative 2.74%, a negative 1.18%, and a positive 0.27%, respectively.

Shopify's last day, last week, and last month's high and low average amplitude percentage was 3.12%, 4.37%, and 4.61%, respectively.

Shopify's Stock Yearly Top and Bottom Value

Shopify's stock is valued at $1,131.95 at 04:22 EST, way below its 52-week high of $1,285.19 and way above its 52-week low of $305.30.

Shopify's Moving Average

Shopify's worth is higher than its 50-day moving average of $1,065.96 and way higher than its 200-day moving average of $1,009.06.

Previous days news about Shopify

According to Bloomberg Quint on Monday, 28 December, "Zoom Video Communications fell 4.3%, while Peloton Interactive lost 4.3% and Shopify declined 3.8%."

According to Business Insider on Tuesday, 29 December, "Technology stocks Sierra Wireless (SW.TO), Shopify Inc. (SHOP.TO) and BlackBerry (BB.TO) lost 6.3%, 4.3% and 4.1%, respectively."

According to The Wall Street Journal on Wednesday, 30 December, "WSJ: How does Radial view the growing competition from digitally oriented companies such as ShipBob Inc. or Shopify Inc., which is also getting into fulfillment?", "Obviously we are aware of what Shopify is doing and others are doing, but, we also feel that we're the best. "

According to Business Insider on Wednesday, 30 December, "A.TO), Shopify Inc. (SHOP.TO), Colliers International (CIGI.TO) and Canadian National Railway (CNR.TO) ended lower by 1 to 3%."

According to Bloomberg Quint on Thursday, 31 December, "Established in 2012 by PayPal Holdings Inc. co-founder Max Levchin, Affirm is also backed by Khosla Ventures, Founders Fund, Lightspeed Venture Partners and Shopify Inc."

According to Bloomberg Quint on Thursday, 31 December, "Some of 2020's biggest technology winners -includingZoom Video Communications Inc., Shopify Inc. and Nvidia Corp. -have delighted shareholders with gains ranging from 100% to 400%. "

3. American Tower Corporation

6.9% sales growth and 34.18% return on equity

American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 181,000 communications sites.

American Tower Corporation's sales growth this year is expected to be 5.1% and 7.5% for next year.

Year-on-year quarterly revenue growth grew by 3%, now sitting on 7.84B for the twelve trailing months.

American Tower Corporation's sales growth for the next quarter is 6.9%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and 48.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.18%.

Volatility

American Tower Corporation's last day, last week, and last month's average volatility was a positive 1.11%, a negative 0.04%, and a negative 0.25%, respectively.

American Tower Corporation's last day, last week, and last month's high and low average amplitude percentage was 1.85%, 1.78%, and 1.99%, respectively.

American Tower Corporation's Stock Yearly Top and Bottom Value

American Tower Corporation's stock is valued at $221.07 at 04:22 EST, way under its 52-week high of $272.20 and way above its 52-week low of $174.32.

American Tower Corporation's Moving Average

American Tower Corporation's worth is below its 50-day moving average of $228.26 and below its 200-day moving average of $245.21.

4. Red River Bancshares, Inc.

29.8% sales growth and 10.56% return on equity

Red River Bancshares, Inc. operates as a bank holding company for Red River Bank that provides banking products and services to commercial and retail customers in Louisiana.

Red River Bancshares, Inc.'s sales growth this year is expected to be 7.1% and 18.8% for next year.

Year-on-year quarterly revenue growth grew by 9.5%, now sitting on 83.77M for the twelve trailing months.

Red River Bancshares, Inc.'s sales growth for the next quarter is 29.8%. The company's growth estimates for the ongoing quarter and the next is a negative 4.3% and negative -5.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.56%.

Volatility

Red River Bancshares, Inc.'s last day, last week, and last month's average volatility was a negative 1.33%, a negative 1.03%, and a negative 0.19%, respectively.

Red River Bancshares, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 0.29%, 2.06%, and 2.41%, respectively.

Red River Bancshares, Inc.'s Stock Yearly Top and Bottom Value

Red River Bancshares, Inc.'s stock is valued at $48.84 at 04:22 EST, way below its 52-week high of $59.00 and way above its 52-week low of $29.90.

Red River Bancshares, Inc.'s Moving Average

Red River Bancshares, Inc.'s worth is under its 50-day moving average of $50.15 and above its 200-day moving average of $45.17.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com